Circulating cell-free DNA for cancer early detection
Q Gao, Q Zeng, Z Wang, C Li, Y Xu, P Cui, X Zhu, H Lu… - The Innovation, 2022 - cell.com
Effective screening modalities are currently available for only a small subset of cancers, and
they generally have suboptimal performance with complicated procedures. Therefore, there …
they generally have suboptimal performance with complicated procedures. Therefore, there …
Anoikis-associated lung cancer metastasis: mechanisms and therapies
J Wang, Z Luo, L Lin, X Sui, L Yu, C Xu, R Zhang… - Cancers, 2022 - mdpi.com
Simple Summary Anoikis is a programmed cell death process resulting from the loss of
interaction between cells and the extracellular matrix. Therefore, it is necessary to overcome …
interaction between cells and the extracellular matrix. Therefore, it is necessary to overcome …
Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
[HTML][HTML] SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection
We review research regarding the epidemiology, risk factors, genetic susceptibility,
molecular pathology, and early detection of SCLC, a deadly tumor that accounts for 14% of …
molecular pathology, and early detection of SCLC, a deadly tumor that accounts for 14% of …
The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
Circular RNA (circRNA) is a novel class of single-stranded RNAs with a closed loop
structure. The majority of circRNAs are formed by a back-splicing process in pre-mRNA …
structure. The majority of circRNAs are formed by a back-splicing process in pre-mRNA …
Artificial intelligence in lung cancer screening: the future is now
Simple Summary Lung cancer is a widespread malignant tumour with a high mortality and
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …
[HTML][HTML] IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
X Xu, J Cui, H Wang, L Ma, X Zhang, W Guo, X Xue… - Materials Today Bio, 2022 - Elsevier
A lack of promising targets leads to poor prognosis in patients with lung adenocarcinoma
(LUAD). Therefore, it is urgent to identify novel therapeutic targets. The importance of the N 6 …
(LUAD). Therefore, it is urgent to identify novel therapeutic targets. The importance of the N 6 …
Common diseases alter the physiological age-related blood microRNA profile
Aging is a key risk factor for chronic diseases of the elderly. MicroRNAs regulate post-
transcriptional gene silencing through base-pair binding on their target mRNAs. We …
transcriptional gene silencing through base-pair binding on their target mRNAs. We …
Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies
C Palanca-Ballester, A Rodriguez-Casanova, S Torres… - Cancers, 2021 - mdpi.com
Simple Summary Apart from genetic changes, cancer is characterized by epigenetic
alterations, which indicate modifications in the DNA (such as DNA methylation) and histones …
alterations, which indicate modifications in the DNA (such as DNA methylation) and histones …
Biomarkers and lung cancer early detection: state of the art
Simple Summary Lung cancer is the leading cause of cancer death worldwide. Detecting
lung malignancies promptly is essential for any anticancer treatment to reduce mortality and …
lung malignancies promptly is essential for any anticancer treatment to reduce mortality and …